Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06464432
Other study ID # 052024_00001
Secondary ID 2023-2024-204
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2024
Est. completion date March 1, 2025

Study information

Verified date June 2024
Source University of Lausanne
Contact Nadine Hosny, MSc
Phone +41766380067
Email nadine.hosny@unil.ch
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: The CPTSD diagnosis presented in the ICD-11 is supposed to provide core and culturally invariant symptoms, which is supported by recent research. Yet, evidence also shows the necessity of integrating culture-specific symptoms in intervention and diagnostic tools to enhance the validity and efficacy of such diagnoses and therapeutic interventions. Along with cultural aspects, there are relevant structural aspects e.g., economic, and social inequalities, which impact mental health. These aspects remain understudied in low middle income countries like Egypt, where there are considerable rates of violence. Aims: The project aims to i) culturally adapt and pilot test the therapeutic manual ESTAIR/MPE in urban Egypt, and ii) to pilot test a cultural and structural module for the diagnostic assessment of CPTSD among the same target population. The objective is to assess the feasibility, acceptability, and initial impact on clinical outcomes of both the manual and diagnostic modules. Methods: In earlier phases, the project gathered qualitative data from key informants on the cultural and structural dimensions of CPTSD in urban Egypt. Using the collected data, investigators culturally adapted this intervention and developed a diagnostic cultural module. Subsequently, the investigators will pilot-test it in four groups of five participants each, 20 participants in total. The project intends to collect both quantitative and qualitative measures to explore determined outcomes and analyze them accordingly.


Description:

For further information, please see the attached protocol.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date March 1, 2025
Est. primary completion date February 15, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Egyptian - 18 years of age or older - Literate, can give written or oral consent - History of severe and/or prolonged trauma, and screen positive for CPTSD - Reside in any other major city Exclusion Criteria: - Imminent risk of suicide, psychotic symptoms, and/or severe alcohol and/or drug abuse - Have been in therapy before (i.e., completed more than 5-10 sessions of psychotherapy)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Enhanced Skills Training in Affective and Interpersonal Regulation
Enhanced Skills Training in Affective and Interpersonal Regulation combined with Modified Prolonged Exposure (ESTAIR); Psychotherapeutic manual for the treatment of Complex Post-Traumatic Stress Disorder (CPTSD) consisting of 4 therapeutic modules: 1. Emotion Regulation, 2, Self-concept, 3. Relationship Patterns, 4. Prolonged Exposure.

Locations

Country Name City State
Egypt The American University in Cairo Cairo

Sponsors (2)

Lead Sponsor Collaborator
University of Lausanne The American University in Cairo

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility ESTAIR Manual We will primarily assess feasibility by determining the percentage of participants who complete the study until the end (among those who sign the informed consent). Based on reported dropout rates from studies using similar modular interventions with trauma survivors, we will consider 80-90% participation and adherence as excellent, 70-80% as satisfactory, and 60-70% as acceptable. 7 months
Primary Acceptability ESTAIR Manual We will assess the acceptability by conducting feedback qualitative interviews after each module and overall feedback on therapy process at the end of therapy. 7 months
Primary Feasibility of ITI-Cultural Module We will assess the ITI feasibility, using the same method based on the percentage of participants who complete the ITI; 80-90% participation and adherence is considered as excellent, 70-80% as satisfactory, and 60-70% as acceptable. 7 months
Primary Acceptability of ITI-Cultural Module We will assess the acceptability of the ITI through qualitative interviews after the diagnostic interview. 7 months
Secondary Complex post-traumatic stress disorder The International Trauma Questionnaire asses 12 symptoms (6 for post-traumatic stress disorder and another 6 for disturbances in self-organisation). A diagnosis of CPTSD requires the endorsement of at least one of the two symptoms from each of the three PTSD symptom clusters described above (i.e., re-experiencing in the here and now, avoidance, and sense of current threat) and at least one of the two symptoms from each of the three Disturbances in Self-Organisation (DSO) clusters (i.e. affective dysregulation, negative self-concept, and disturbances in relationships). Items are scored on a Likert scale ranging from 0 (not at all) to 4 (extremely).
The endorsement of a symptom item is defined as a score = 2.
7 months
Secondary Depression Patient Health Questionnaire (PHQ-9). The PHQ-9 score may range from 0 to 27, since each of the 9 items can be scored from 0 (not at all) to 3 (nearly every day). Higher scores mean higher levels of depression. 7 months
Secondary Anxiety General Anxiety Disorder Questionnaire (GAD-7). The GAD-7 score may range from 0 to 21, since each of the 7 items can be scored from 0 (not at all) to 3 (nearly every day). Higher scores mean higher levels of anxiety. 7 months
Secondary Somatic Symptoms Somatic Symptoms Scale (SSS-8). The SSS-8 score may range from 0 to 32, since each of the 8 items can be scored from 0 (not at all) to 4 (severely). Higher scores mean higher levels of somatic symptoms. 7 months
Secondary Well-being WHO-5 questionnaire. Scores range from 0-25, based on a Likert scale from 0 (not at all) to 5 (all of the time) for each item. Higher scores reflect better levels of well-being. 7 months
See also
  Status Clinical Trial Phase
Recruiting NCT05917613 - Complex-Posttraumatic Stress Disorder - Cultural Adaptation of a Therapeutic Manual and Development of a Culture-specific Diagnostic Module for Refugee Populations in Switzerland (Pilot Trial) N/A
Not yet recruiting NCT04887168 - Survive & Thrive Trial With Male Offenders N/A
Completed NCT05993468 - A Pilot Study of a Trauma-Sensitive Mindfulness and Compassion Intervention
Not yet recruiting NCT06233968 - Using Data Science To Center Patient Perspectives in Mechanism Discovery
Completed NCT05281640 - Psychological Interventions for Complex PTSD And Schizophrenia-Spectrum Disorder: PICASSO Trial N/A
Recruiting NCT04752072 - RESTORE Trial: A Pilot RCT of Enhanced Skills Training in Affective and Interpersonal Regulation (ESTAIR) for Veterans With CPTSD N/A
Recruiting NCT05259592 - Modular Patient Centred CBT for Danish Veterans With Complex PTSD Phase 1/Phase 2
Completed NCT04594434 - Eye Movement Desensitization and Reprocessing (EMDR) in Complex Psychotrauma N/A
Completed NCT04532996 - Trauma-focused Psychodynamic Psychotherapy for LGBT Patients With Post-traumatic Stress Disorder N/A
Recruiting NCT06007612 - Context Sensitivity in Emotion Regulation in Post-Traumatic Stress Disorder N/A